Passive immunotherapies protect WRvFire and IHD-J-Luc vaccinia virus-infected mice from lethality by reducing viral loads in the upper respiratory tract and internal organs - Wikidata - wikimedia - TriplyDB

Passive immunotherapies protect WRvFire and IHD-J-Luc vaccinia virus-infected mice from lethality by reducing viral loads in the upper respiratory tract and internal organs

Passive immunotherapies protect WRvFire and IHD-J-Luc vaccinia virus-infected mice from lethality by reducing viral loads in the upper respiratory tract and internal organs

http://www.wikidata.org/entity/Q35192889

about

Use of Reporter Genes in the Generation of Vaccinia Virus-Derived Vectors Back to the future: recombinant polyclonal antibody therapeutics.Effect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model.Postchallenge administration of brincidofovir protects healthy and immune-deficient mice reconstituted with limited numbers of T cells from lethal challenge with IHD-J-Luc vaccinia virus.Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease.Effects of postchallenge administration of ST-246 on dissemination of IHD-J-Luc vaccinia virus in normal mice and in immune-deficient mice reconstituted with T cells Susceptibility of the wild-derived inbred CAST/Ei mouse to infection by orthopoxviruses analyzed by live bioluminescence imaging.Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections

P2860

Q26746915-505D05FD-D0E6-4C14-92A0-66A994C81249 Q33412776-E595F41C-6DB2-43DE-B535-12BD7204052E Q34779016-6C2D7B48-24D2-4F7E-8FA4-1365AAD96CBD Q35110971-D4B3C935-5723-40F4-B0FE-ED44BF90DBD8 Q35339702-27A153B5-EB2A-441A-AA4F-9BCCA5EB2A99 Q36827391-359B24A0-C541-4B23-A7DF-9BFA993365EF Q37516020-08BACC01-FF57-4842-81CF-2FD1689C9846 Q40494092-BBB18E83-3943-4DE5-9A2B-227415390862

P2860

Passive immunotherapies protect WRvFire and IHD-J-Luc vaccinia virus-infected mice from lethality by reducing viral loads in the upper respiratory tract and internal organs

http://www.wikidata.org/entity/Q35192889

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Passive immunotherapies protec ...... tory tract and internal organs

@ast

Passive immunotherapies protec ...... tory tract and internal organs

@en

type

label

Passive immunotherapies protec ...... tory tract and internal organs

@ast

Passive immunotherapies protec ...... tory tract and internal organs

@en

prefLabel

Passive immunotherapies protec ...... tory tract and internal organs

@ast

Passive immunotherapies protec ...... tory tract and internal organs

@en

P1433

Q35192889-DD686DBE-82FD-4085-B96B-368F09F95E50

P1476

Q35192889-0A8813B4-105A-47F9-9205-950038826EBC

P2093

Q35192889-2091D94D-BFE3-4BA9-AD2A-F64EEC5612A0

Q35192889-295B184F-A815-447B-AC8D-E9059B5646C6

Q35192889-2BB946F3-71AB-4A31-90C8-8E0510F308BB

Q35192889-6A21AD36-856E-4F52-A7A8-48B1DE168C3E

Q35192889-A906771A-83A2-470D-A276-5F1BFC747767

Q35192889-B6296AEE-A67C-4709-8858-C7DECC9CE534

Q35192889-C0C0D288-5978-4E6E-A94D-E3481B4C16BE

Q35192889-C9958B29-41DC-4B25-9CD5-EAA12E0762E6

Q35192889-DD5C422E-77C4-43E8-951E-30BBA415E5F2

Q35192889-EBAC21CA-BBDA-4FA1-A41F-68F297C37C00

P2860

Q35192889-00F616DC-3B58-464D-80CA-FA1DA111FE29

Q35192889-095C9B2D-1B82-4EB6-BF3D-5730E799BFE8

Q35192889-09C3A11D-5B0A-4BFF-A3BE-91C8C6B1243B

Q35192889-10EB8F85-B349-496C-9601-F6B3ACC6C295

Q35192889-2BB3224C-75BA-48FC-8913-819D4ED7FB6A

Q35192889-5E9DFE2A-20F8-456B-AAD0-4F2511FD9946

Q35192889-61CD391F-F764-46CA-8DC1-1814A101CF5B

Q35192889-637BC059-B34B-45A8-9707-EBB63B8ECC06

Q35192889-70FCFB65-34DD-4F89-97E1-1B49B61FC1F2

Q35192889-752D921D-4778-4A73-B3A5-22C488BD072A

P304

Q35192889-B3242235-19E3-46ED-84E3-BA7253091921

P31

Q35192889-9D40E2B3-F497-4A77-97D3-285BFD3AAD04

P356

Q35192889-69FB4057-5BD3-419B-92C5-D193C7A744D4

P407

Q35192889-E41F972D-5BAD-46D0-B621-52004D9151B5

P433

Q35192889-40A52C9D-FDCC-4480-A2A1-166335F5A158

P478

Q35192889-A2BCBAC0-E940-4BB1-96CE-F189EC338917

P50

Q35192889-1B326628-54F4-4C4C-9BFD-CD50CCD9EBD7

Q35192889-E8627746-C6F0-4CE5-A5E7-08F175F69A97

P577

Q35192889-AB9DEA48-0F45-4B33-B229-CA02F6DF2EB5

P5875

Q35192889-122544CC-012D-40B3-9234-ACE4766CDB37

P698

Q35192889-85B2A082-3B99-4ED1-8673-F1EAEFDBAEC9

P921

Q35192889-EAB15369-A954-4054-AB12-A4B0DFBCA77C

P932

Q35192889-6D5B8A3C-2812-438E-A530-5D280E15E43E

P356

P1433

Journal of Virology

P1476

Passive immunotherapies protec ...... tory tract and internal organs

@en

P2093

Clement A Meseda

http://www.w3.org/2001/XMLSchema#string

Elisabeth Shotwell

http://www.w3.org/2001/XMLSchema#string

Hana Golding

http://www.w3.org/2001/XMLSchema#string

Henriette Nielsen

http://www.w3.org/2001/XMLSchema#string

Jerry P Weir

http://www.w3.org/2001/XMLSchema#string

Jody Manischewitz

http://www.w3.org/2001/XMLSchema#string

Lisa R King

http://www.w3.org/2001/XMLSchema#string

Marina Zaitseva

http://www.w3.org/2001/XMLSchema#string

Michael Merchlinsky

http://www.w3.org/2001/XMLSchema#string

Senta M Kapnick

http://www.w3.org/2001/XMLSchema#string

P2860

Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox

Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy.

Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001.

ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain)--a second-generation smallpox vaccine for biological defense.

Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).

Smallpox vaccination and adverse reactions. Guidance for clinicians.

Repulsion of superinfecting virions: a mechanism for rapid virus spread.

Isolation of human antibody repertoires with preservation of the natural heavy and light chain pairing.

Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.

Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge

P304

9147-9158

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00121-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51454071

http://www.w3.org/2001/XMLSchema#string

P698

21715493

http://www.w3.org/2001/XMLSchema#string

P921

P932

3165812

http://www.w3.org/2001/XMLSchema#string